Drug Discovery / Development
As for drug discovery, it is said that it takes more than 10 years from candidate selection to commercialization. Most candidate compounds will be withdrawn from development midway due to issues such as efficacy, safety, or quality. Drug development thus requires efficient and appropriate evaluation of effective compounds in the initial stage of drug discovery. Fujifilm Wako offers a lineup of reagents that are useful for screening candidate compounds and evaluating their efficacy and safety.
Product Line-up
-
- Integrated Drug Discovery Service for Infectious Disease
- Drug Discovery Service: Cardiotoxicity Testing with Human iPSC-derived Cardiomyocytes
- Rabbit Monoclonal Antibody Discovery Using DNA Immunization
- AI and chemical simulation-based drug discovery support service
- Fluorospark™ Kinase/ADP Multi-Assay Kit
For research use or further manufacturing use only. Not for use in diagnostic procedures.
Product content may differ from the actual image due to minor specification changes etc.
If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.